Drug Side Effects
Search
ACQUIRED POROKERATOSIS
ACQUIRED POROKERATOSIS
was reported 29 times
ACQUIRED POROKERATOSIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Provitamin D2 Compound [EPC]
2
0.0001
1
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]
1
0.0001
2
Antirheumatic Agent [EPC]
6
0.0001
3
Aromatase Inhibitor [EPC]
6
0.0001
4
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
1
0.0000
5
Topoisomerase Inhibitor [EPC]
2
0.0000
6
Calcineurin Inhibitor Immunosuppressant [EPC]
3
0.0000
7
Hepatitis C Virus NS5A Inhibitor [EPC]
1
0.0000
8
Programmed Death Receptor-1 Blocking Antibody [EPC]
2
0.0000
9
Platinum-based Drug [EPC]
3
0.0000
10
Platelet Aggregation Inhibitor [EPC]
5
0.0000
11
Alkylating Drug [EPC]
2
0.0000
12
HMG-CoA Reductase Inhibitor [EPC]
3
0.0000
13
Selective T Cell Costimulation Modulator [EPC]
1
0.0000
14
Corticosteroid [EPC]
9
0.0000
15
Folate Analog Metabolic Inhibitor [EPC]
3
0.0000
16
Janus Kinase Inhibitor [EPC]
1
0.0000
17
Microtubule Inhibitor [EPC]
1
0.0000
18
Nonsteroidal Anti-inflammatory Drug [EPC]
5
0.0000
19
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
20
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
21
Proton Pump Inhibitor [EPC]
1
0.0000